← FDA Drug Approvals (Drugs@FDA)

MOMETASONE FUROATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2017-04-03

Drug application

FDA Application #

ANDA207989

Application type

Abbreviated New Drug Application (Generic)

Brand name

MOMETASONE FUROATE

Generic name

MOMETASONE

Active ingredients

MOMETASONE FUROATE

Dosage form

SPRAY, METERED

Route

NASAL

Marketing status

Prescription

Sponsor

AMNEAL PHARMS

Manufacturer

Amneal Pharmaceuticals LLC

First approval

2017-04-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown